Table 2

Risk factor distribution by age groups at baseline

Risk factor distribution (n=66 951)
40–49 years
(n=24 914)
50–59 years
(n=21 824)
60–69 years
(n=13 441)
≥70 years
(n=6772)
BMI (kg/m2)25.5 (23.1 to 28.4)26.8 (24.2 to 29.8)27.5 (24.8 to 30.7)27.0 (24.3 to 30.1)
 <3020 806 (84.0)16 418 (75.8)9414 (70.6)4949 (73.8)
 ≥303951 (16.0)5250 (24.2)3926 (29.4)1757 (26.2)
Systolic blood pressure (mm Hg)*129 (119 to 141)138 (125 to 152)145 (132 to 160)154 (140 to 170)
 <14018 097 (73.1)11 658 (53.8)5277 (39.6)1667 (24.8)
 ≥1406656 (26.9)10 023 (46.2)8058 (60.4)5056 (75.2)
Diabetes539 (2.2)1115 (5.1)1196 (8.9)676 (10.0)
Daily smoker7802 (31.4)5871 (27.0)2628 (19.7)1004 (15.0)
Taking antihypertensive drugs1608 (7.0)3958 (19.6)3989 (31.3)2422 (36.9)
Hypertension†7389 (31.6)11 423 (54.7)9150 (69.5)5508 (82.2)
Total serum cholesterol (mmol/L)5.7 (5.0 to 6.5)6.1 (5.3 to 6.9)6.1 (5.3 to 6.9)6.1 (5.3 to 7.1)
 ≤6.518 830 (76.3)14 074 (65.1)8556 (64.4)4162 (62.3)
 >6.55859 (23.7)7558 (34.9)4721 (35.6)2522 (37.7)
Average daily alcohol consumption (g)3.0 (0.0 to 12.0)3.0 (0.0 to 12.0)2.0 (0.0 to 11.0)2.0 (0.0 to 12.0)
History of MI or stroke285 (1.1)1024 (4.7)1255 (9.3)1061 (15.7)
eGFR‡104.7 (93.9 to 109.3)96.9 (85.5 to 101.9)89.8 (78.2 to 95.0)81.9 (69.9 to 87.9)
C reactive protein (mg/L)1.0 (0.5 to 2.2)1.4 (0.7 to 3.0)1.7 (0.9 to 3.6)1.9 (1.0 to 3.9)
Nt-proBNP (pg/mL)35.9 (19.8 to 62.3)44.9 (25.1 to 78.9)70.8 (40.2 to 125.5)126.6 (70.8 to 228.4)
log10 (Nt -proBNP (pg/mL))1.6 (1.3 to 1.8)1.7 (1.4 to 1.9)1.9 (1.6 to 2.1)2.1 (1.8 to 2.4)
  • Continuous variables are presented as median and IQR (25th and 75th percentile), binary variables as absolute and relative frequencies.

  • *Mean of two measurements.

  • †Systolic blood pressure ≥140 mm Hg and/or taking antihypertensive drugs.

  • ‡Using the Chronic Kidney Disease Epidemiology Collaboration formula with creatinine.

  • BMI, body mass index; eGFR, estimated glomerular filtration rate; MI, myocardial infarction; Nt-pro-BN, N-terminal-pro B-type natriuretic peptide.